AllianceBernstein
CBIO

AllianceBernstein’s Crescent Biopharma CBIO Stock Holding History

AllianceBernstein’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-728
Closed -$219K – 3357
2021
Q1 		$219K Hold
728
– – ﹤0.01% 3026
2020
Q4 		$274K Hold
728
– – ﹤0.01% 2899
2020
Q3 		$223K Sell
728
-26
-3% -$9.94K ﹤0.01% 2933
2020
Q2 		$284K Buy
754
+276
+58% +$78.1K ﹤0.01% 2901
2020
Q1 		$109K Buy
478
+42
+10% +$16.1K ﹤0.01% 2942
2019
Q4 		$231K Hold
436
– – ﹤0.01% 2874
2019
Q3 		$188K Buy
436
+71
+19% +$45.7K ﹤0.01% 2962
2019
Q2 		$435K Buy
365
+42
+13% +$50.2K ﹤0.01% 2665
2019
Q1 		$402K Buy
323
+40
+14% +$45.8K ﹤0.01% 2623
2018
Q4 		$268K Buy
283
+58
+26% +$69.8K ﹤0.01% 2778
2018
Q3 		$324K Buy
225
+69
+44% +$104K ﹤0.01% 2810
2018
Q2 		$252K Buy
+156
New +$268K ﹤0.01% 2876
2014
Q2 		– Sell
-2
Closed -$3K – 3497
2014
Q1 		$3K Buy
+2
New +$2.42K ﹤0.01% 3369

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return